PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"26962941","Macrophages and HIV-1: An Unhealthy Constellation","Sattentau QJ, Stevenson M.","Cell Host Microbe. 2016 Mar 9;19(3):304-10. doi: 10.1016/j.chom.2016.02.013.","Sattentau QJ","Cell Host Microbe","2016","2016/03/11","PMC5453177","NIHMS763558","10.1016/j.chom.2016.02.013"
"31175817","Next-Generation Preexposure Prophylaxis: Choices For Effective HIV Prevention","Mugwanya KK, Baeten JM.","J Infect Dis. 2020 Apr 7;221(9):1387-1389. doi: 10.1093/infdis/jiz273.","Mugwanya KK","J Infect Dis","2020","2019/06/09","PMC7137882","","10.1093/infdis/jiz273"
"22415473","HIV-1 prevention for HIV-1 serodiscordant couples","Curran K, Baeten JM, Coates TJ, Kurth A, Mugo NR, Celum C.","Curr HIV/AIDS Rep. 2012 Jun;9(2):160-70. doi: 10.1007/s11904-012-0114-z.","Curran K","Curr HIV/AIDS Rep","2012","2012/03/15","PMC3570050","NIHMS438113","10.1007/s11904-012-0114-z"
"26613994","Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment","Singer EJ, Thames AD.","Neurol Clin. 2016 Feb;34(1):33-53. doi: 10.1016/j.ncl.2015.08.003.","Singer EJ","Neurol Clin","2016","2015/11/29","PMC4663681","NIHMS733127","10.1016/j.ncl.2015.08.003"
"27447446","Humanized mice for HIV and AIDS research","Victor Garcia J.","Curr Opin Virol. 2016 Aug;19:56-64. doi: 10.1016/j.coviro.2016.06.010. Epub 2016 Jul 19.","Victor Garcia J","Curr Opin Virol","2016","2016/07/23","PMC5021593","NIHMS804654","10.1016/j.coviro.2016.06.010"
"25304006","Optimizing ART adherence: update for HIV treatment and prevention","Robbins RN, Spector AY, Mellins CA, Remien RH.","Curr HIV/AIDS Rep. 2014 Dec;11(4):423-33. doi: 10.1007/s11904-014-0229-5.","Robbins RN","Curr HIV/AIDS Rep","2014","2014/10/12","PMC4268351","NIHMS634790","10.1007/s11904-014-0229-5"
"37952550","Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial","Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B; HPTN 083 Study Team.","Lancet HIV. 2023 Dec;10(12):e767-e778. doi: 10.1016/S2352-3018(23)00261-8. Epub 2023 Nov 9.","Landovitz RJ","Lancet HIV","2023","2023/11/12","PMC11375758","NIHMS2017279","10.1016/S2352-3018(23)00261-8"
"32992787","Macrophage Tropism in Pathogenic HIV-1 and SIV Infections","Moeser M, Nielsen JR, Joseph SB.","Viruses. 2020 Sep 25;12(10):1077. doi: 10.3390/v12101077.","Moeser M","Viruses","2020","2020/09/30","PMC7601331","","10.3390/v12101077"
"28615975","Pre-exposure prophylaxis for HIV prevention in women: current perspectives","Flash CA, Dale SK, Krakower DS.","Int J Womens Health. 2017 May 31;9:391-401. doi: 10.2147/IJWH.S113675. eCollection 2017.","Flash CA","Int J Womens Health","2017","2017/06/16","PMC5459979","","10.2147/IJWH.S113675"
"11268377","Psychoneuroimmunology and HIV/AIDS","Solomon GF, Ironson GH, Balbin EG.","Ann N Y Acad Sci. 2000;917:500-4. doi: 10.1111/j.1749-6632.2000.tb05414.x.","Solomon GF","Ann N Y Acad Sci","2000","2001/03/28","","","10.1111/j.1749-6632.2000.tb05414.x"
"28886986","Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS","Malik S, Eugenin EA.","Neurosci Lett. 2019 Mar 16;695:86-90. doi: 10.1016/j.neulet.2017.09.005. Epub 2017 Sep 5.","Malik S","Neurosci Lett","2019","2017/09/10","PMC5837894","NIHMS905618","10.1016/j.neulet.2017.09.005"
"23073703","Pharmacists as providers of HIV pre-exposure prophylaxis","Bruno C, Saberi P.","Int J Clin Pharm. 2012 Dec;34(6):803-6. doi: 10.1007/s11096-012-9709-0. Epub 2012 Oct 17.","Bruno C","Int J Clin Pharm","2012","2012/10/18","PMC3501608","NIHMS415425","10.1007/s11096-012-9709-0"
"27122594","Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?","Krakower DS, Mayer KH.","J Infect Dis. 2016 Oct 1;214(7):983-5. doi: 10.1093/infdis/jiw169. Epub 2016 Apr 27.","Krakower DS","J Infect Dis","2016","2016/04/29","PMC5021225","","10.1093/infdis/jiw169"
"33128874","Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention","Rowan SE, Patel RR, Schneider JA, Smith DK.","Lancet HIV. 2021 Feb;8(2):e114-e120. doi: 10.1016/S2352-3018(20)30256-3. Epub 2020 Oct 28.","Rowan SE","Lancet HIV","2021","2020/10/31","","","10.1016/S2352-3018(20)30256-3"
"34949264","Urgent appeal to implement pre-exposure prophylaxis for pregnant and breastfeeding women in South Africa","Joseph Davey DL, Davies N, Raphael Y, Pillay Y, Bekker LG.","S Afr Med J. 2021 Oct 6;111(11):1038-1039.","Joseph Davey DL","S Afr Med J","2021","2021/12/24","PMC9190765","NIHMS1811341",""
"35126374","Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy","Mohamed H, Gurrola T, Berman R, Collins M, Sariyer IK, Nonnemacher MR, Wigdahl B.","Front Immunol. 2022 Jan 20;12:816515. doi: 10.3389/fimmu.2021.816515. eCollection 2021.","Mohamed H","Front Immunol","2022","2022/02/07","PMC8811197","","10.3389/fimmu.2021.816515"
"26103095","Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm","Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, Anderson P, Mugo N, Venter F, Goicochea P, Caceres C, O'Reilly K.","AIDS. 2015 Jul 17;29(11):1277-85. doi: 10.1097/QAD.0000000000000647.","Haberer JE","AIDS","2015","2015/06/24","PMC4480436","NIHMS671261","10.1097/QAD.0000000000000647"
"34452331","Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis","Khan N, Geiger JD.","Viruses. 2021 Jul 27;13(8):1466. doi: 10.3390/v13081466.","Khan N","Viruses","2021","2021/08/28","PMC8402909","","10.3390/v13081466"
"37698802","Medical mistrust as a barrier to HIV prevention and care","El-Krab R, Brousseau N, Kalichman SC.","J Behav Med. 2023 Dec;46(6):897-911. doi: 10.1007/s10865-023-00417-7. Epub 2023 Sep 12.","El-Krab R","J Behav Med","2023","2023/09/12","","","10.1007/s10865-023-00417-7"
"34191532","1981-2021: HIV and Our World","Landers S, Kapadia F, Bowleg L.","Am J Public Health. 2021 Jul;111(7):1180-1182. doi: 10.2105/AJPH.2021.306360. Epub 2021 Jun 30.","Landers S","Am J Public Health","2021","2021/06/30","PMC8493161","","10.2105/AJPH.2021.306360"
"26793265","Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US","Scott HM, Klausner JD.","AIDS Res Ther. 2016 Jan 19;13:5. doi: 10.1186/s12981-016-0089-8. eCollection 2016.","Scott HM","AIDS Res Ther","2016","2016/01/22","PMC4719214","","10.1186/s12981-016-0089-8"
"31800270","Leveraging Medicaid to Enhance Preexposure Prophylaxis Implementation Efforts and Ending the HIV Epidemic","Chan PA, Seiler N, Chu CT.","Am J Public Health. 2020 Jan;110(1):65-66. doi: 10.2105/AJPH.2019.305416.","Chan PA","Am J Public Health","2020","2019/12/05","PMC6893350","","10.2105/AJPH.2019.305416"
"31965523","On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know","Saberi P, Scott HM.","J Gen Intern Med. 2020 Apr;35(4):1285-1288. doi: 10.1007/s11606-020-05651-2. Epub 2020 Jan 21.","Saberi P","J Gen Intern Med","2020","2020/01/23","PMC7174437","","10.1007/s11606-020-05651-2"
"22156901","Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence","Celum C, Baeten JM.","Curr Opin Infect Dis. 2012 Feb;25(1):51-7. doi: 10.1097/QCO.0b013e32834ef5ef.","Celum C","Curr Opin Infect Dis","2012","2011/12/14","PMC3266126","NIHMS348495","10.1097/QCO.0b013e32834ef5ef"
"32221469","Potential Impact of Targeted HIV Pre-Exposure Prophylaxis Uptake Among Male Sex Workers","Goedel WC, Mimiaga MJ, King MRF, Safren SA, Mayer KH, Chan PA, Marshall BDL, Biello KB.","Sci Rep. 2020 Mar 27;10(1):5650. doi: 10.1038/s41598-020-62694-5.","Goedel WC","Sci Rep","2020","2020/03/30","PMC7101419","","10.1038/s41598-020-62694-5"
"23221365","Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis","Celum C, Baeten JM.","Antivir Ther. 2012;17(8):1483-93. doi: 10.3851/IMP2492. Epub 2012 Dec 7.","Celum C","Antivir Ther","2012","2012/12/11","PMC3531985","NIHMS429706","10.3851/IMP2492"
"36973419","Monocyte-derived macrophages contain persistent latent HIV reservoirs","Veenhuis RT, Abreu CM, Costa PAG, Ferreira EA, Ratliff J, Pohlenz L, Shirk EN, Rubin LH, Blankson JN, Gama L, Clements JE.","Nat Microbiol. 2023 May;8(5):833-844. doi: 10.1038/s41564-023-01349-3. Epub 2023 Mar 27.","Veenhuis RT","Nat Microbiol","2023","2023/03/27","PMC10159852","NIHMS1891209","10.1038/s41564-023-01349-3"
"34623888","Provider Comfort with Prescribing HIV Pre-Exposure Prophylaxis to Adolescents","Pina P, Taggart T, Sanchez Acosta M, Eweka I, Muñoz-Laboy M, Albritton T.","AIDS Patient Care STDS. 2021 Oct;35(10):411-417. doi: 10.1089/apc.2021.0045.","Pina P","AIDS Patient Care STDS","2021","2021/10/08","PMC8665811","","10.1089/apc.2021.0045"
"25216985","Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches","Brown JL, Sales JM, DiClemente RJ.","Curr HIV/AIDS Rep. 2014 Dec;11(4):363-75. doi: 10.1007/s11904-014-0228-6.","Brown JL","Curr HIV/AIDS Rep","2014","2014/09/14","PMC4358895","NIHMS628286","10.1007/s11904-014-0228-6"
"32347446","Artificial Intelligence and Machine Learning for HIV Prevention: Emerging Approaches to Ending the Epidemic","Marcus JL, Sewell WC, Balzer LB, Krakower DS.","Curr HIV/AIDS Rep. 2020 Jun;17(3):171-179. doi: 10.1007/s11904-020-00490-6.","Marcus JL","Curr HIV/AIDS Rep","2020","2020/04/30","PMC7260108","NIHMS1589053","10.1007/s11904-020-00490-6"
"20679759","Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation","Matthews LT, Baeten JM, Celum C, Bangsberg DR.","AIDS. 2010 Aug 24;24(13):1975-82. doi: 10.1097/QAD.0b013e32833bedeb.","Matthews LT","AIDS","2010","2010/08/04","PMC3773599","NIHMS496697","10.1097/QAD.0b013e32833bedeb"
"18447615","Antiretroviral therapy and central nervous system HIV type 1 infection","Price RW, Spudich S.","J Infect Dis. 2008 May 15;197 Suppl 3(Suppl 3):S294-306. doi: 10.1086/533419.","Price RW","J Infect Dis","2008","2008/06/14","PMC2628635","NIHMS78870","10.1086/533419"
"32105164","Interest and Knowledge of HIV Pre-Exposure Prophylaxis in a Unified Jail and Prison Setting","Brinkley-Rubinstein L, Crowley C, Montgomery MC, Peterson M, Zaller N, Martin R, Clarke J, Dubey M, Chan PA.","J Correct Health Care. 2020 Jan;26(1):36-41. doi: 10.1177/1078345819897405. Epub 2020 Feb 27.","Brinkley-Rubinstein L","J Correct Health Care","2020","2020/02/28","","","10.1177/1078345819897405"
"18780234","Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS","Crews L, Lentz MR, Gonzalez RG, Fox HS, Masliah E.","J Neurovirol. 2008 Aug;14(4):327-39. doi: 10.1080/13550280802132840.","Crews L","J Neurovirol","2008","2008/09/10","PMC2562423","NIHMS70071","10.1080/13550280802132840"
"33219492","Addressing Unhealthy Alcohol Use and the HIV Pre-exposure Prophylaxis Care Continuum in Primary Care: A Scoping Review","Oldfield BJ, Edelman EJ.","AIDS Behav. 2021 Jun;25(6):1777-1789. doi: 10.1007/s10461-020-03107-6. Epub 2020 Nov 20.","Oldfield BJ","AIDS Behav","2021","2020/11/21","PMC8084877","NIHMS1648817","10.1007/s10461-020-03107-6"
"31517525","Improving the Youth HIV Prevention and Care Cascades: Innovative Designs in the Adolescent Trials Network for HIV/AIDS Interventions","Naar S, Hudgens MG, Brookmeyer R, Idalski Carcone A, Chapman J, Chowdhury S, Ciaranello A, Comulada WS, Ghosh S, Horvath KJ, Ingram L, LeGrand S, Reback CJ, Simpson K, Stanton B, Starks T, Swendeman D.","AIDS Patient Care STDS. 2019 Sep;33(9):388-398. doi: 10.1089/apc.2019.0095.","Naar S","AIDS Patient Care STDS","2019","2019/09/14","PMC6745528","","10.1089/apc.2019.0095"
"28060019","Defining the HIV pre-exposure prophylaxis care continuum","Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, Chan PA.","AIDS. 2017 Mar 13;31(5):731-734. doi: 10.1097/QAD.0000000000001385.","Nunn AS","AIDS","2017","2017/01/07","PMC5333727","","10.1097/QAD.0000000000001385"
"19472057","Functional consequences of HIV-associated neuropsychological impairment","Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van Gorp WG.","Neuropsychol Rev. 2009 Jun;19(2):186-203. doi: 10.1007/s11065-009-9095-0. Epub 2009 May 27.","Gorman AA","Neuropsychol Rev","2009","2009/05/28","PMC2871666","NIHMS197466","10.1007/s11065-009-9095-0"
"34114166","Characterizing the Impact of COVID-19 on Pre-Exposure Prophylaxis (PrEP) Care","Rogers BG, Tao J, Maynard M, Chu C, Silva E, Toma E, Nagel K, Napoleon S, Chan PA.","AIDS Behav. 2021 Nov;25(11):3754-3757. doi: 10.1007/s10461-021-03337-2. Epub 2021 Jun 10.","Rogers BG","AIDS Behav","2021","2021/06/11","PMC8191705","","10.1007/s10461-021-03337-2"
"29084044","Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States","Mayer KH, Chan PA, R Patel R, Flash CA, Krakower DS.","J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):119-127. doi: 10.1097/QAI.0000000000001579.","Mayer KH","J Acquir Immune Defic Syndr","2018","2017/10/31","PMC5762416","NIHMS914941","10.1097/QAI.0000000000001579"
"35142705","Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations","Mangurian C, Dahiya P, Goldman ML, Corbeil T, Wall MM, Essock SM, Dixon LB, Tang F, Frimpong E, Mascayano F, Radigan M, Wang R, Olfson M, Smith TE.","AIDS. 2022 Jun 1;36(7):1031-1037. doi: 10.1097/QAD.0000000000003190. Epub 2022 Feb 9.","Mangurian C","AIDS","2022","2022/02/10","PMC9167207","NIHMS1778516","10.1097/QAD.0000000000003190"
"33575901","Community Belonging and Attitudes Towards HIV Pre-Exposure Prophylaxis (PrEP) Among Transgender Women","D'Avanzo PA, Bass SB, Kelly PJ, Brajuha J, Gutierrez-Mock L, Sevelius J.","AIDS Behav. 2021 Sep;25(9):2728-2742. doi: 10.1007/s10461-021-03183-2. Epub 2021 Feb 11.","D'Avanzo PA","AIDS Behav","2021","2021/02/12","PMC8355232","NIHMS1702089","10.1007/s10461-021-03183-2"
"23570851","HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact","Celum C, Hallett TB, Baeten JM.","J Infect Dis. 2013 Jul 15;208(2):189-91. doi: 10.1093/infdis/jit154. Epub 2013 Apr 9.","Celum C","J Infect Dis","2013","2013/04/11","PMC3685227","","10.1093/infdis/jit154"
"26270691","Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia","Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, Rosenberg ES.","Clin Infect Dis. 2015 Nov 15;61(10):1590-7. doi: 10.1093/cid/civ664. Epub 2015 Aug 13.","Kelley CF","Clin Infect Dis","2015","2015/08/14","PMC4614414","","10.1093/cid/civ664"
"31688333","The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment","Castor D, Meyers K, Allen S.","Curr Opin HIV AIDS. 2020 Jan;15(1):73-80. doi: 10.1097/COH.0000000000000601.","Castor D","Curr Opin HIV AIDS","2020","2019/11/06","PMC6903331","","10.1097/COH.0000000000000601"
"21286833","Mitogen-activated protein kinase p38 in HIV infection and associated brain injury","Medders KE, Kaul M.","J Neuroimmune Pharmacol. 2011 Jun;6(2):202-15. doi: 10.1007/s11481-011-9260-0. Epub 2011 Feb 1.","Medders KE","J Neuroimmune Pharmacol","2011","2011/02/03","PMC3690763","NIHMS476482","10.1007/s11481-011-9260-0"
"31509603","Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation","Spinelli MA, Buchbinder SP.","Clin Infect Dis. 2020 Jul 27;71(3):583-585. doi: 10.1093/cid/ciz896.","Spinelli MA","Clin Infect Dis","2020","2019/09/12","PMC7384308","","10.1093/cid/ciz896"
"37249729","Using Motivational Interviewing to Increase HIV PrEP Initiation and Adherence: a Scoping Review","Dangerfield DT 2nd, Davis G, Pandian V, Anderson JN.","Prev Sci. 2023 Oct;24(7):1365-1375. doi: 10.1007/s11121-023-01554-w. Epub 2023 May 30.","Dangerfield DT 2nd","Prev Sci","2023","2023/05/30","PMC10575988","","10.1007/s11121-023-01554-w"
"2181001","Human immunodeficiency virus-type 1 (HIV-1) and the brain","Grant I, Heaton RK.","J Consult Clin Psychol. 1990 Feb;58(1):22-30. doi: 10.1037//0022-006x.58.1.22.","Grant I","J Consult Clin Psychol","1990","1990/02/01","","","10.1037//0022-006x.58.1.22"
"30114997","Lessons from a decade of voluntary medical male circumcision implementation and their application to HIV pre-exposure prophylaxis scale up","Reed JB, Patel RR, Baggaley R.","Int J STD AIDS. 2018 Dec;29(14):1432-1443. doi: 10.1177/0956462418787896. Epub 2018 Aug 16.","Reed JB","Int J STD AIDS","2018","2018/08/18","PMC6287252","","10.1177/0956462418787896"
"36044375","Animal models for studies of HIV-1 brain reservoirs","Waight E, Zhang C, Mathews S, Kevadiya BD, Lloyd KCK, Gendelman HE, Gorantla S, Poluektova LY, Dash PK.","J Leukoc Biol. 2022 Nov;112(5):1285-1295. doi: 10.1002/JLB.5VMR0322-161R. Epub 2022 Aug 31.","Waight E","J Leukoc Biol","2022","2022/08/31","PMC9804185","","10.1002/JLB.5VMR0322-161R"
"36029425","Development and Validation of the Youth Pre-Exposure Prophylaxis (PrEP) Stigma Scale","Budhwani H, Yiğit İ, Maragh-Bass AC, Rainer CB, Claude K, Muessig KE, Hightow-Weidman LB.","AIDS Behav. 2023 Mar;27(3):929-938. doi: 10.1007/s10461-022-03829-9. Epub 2022 Aug 27.","Budhwani H","AIDS Behav","2023","2022/08/27","PMC9968821","NIHMS1859685","10.1007/s10461-022-03829-9"
"29020235","Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures","Marcus JL, Hurley LB, Nguyen DP, Silverberg MJ, Volk JE.","Clin Infect Dis. 2017 Oct 30;65(10):1768-1769. doi: 10.1093/cid/cix593.","Marcus JL","Clin Infect Dis","2017","2017/10/12","PMC5849999","","10.1093/cid/cix593"
"29977959","Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network","Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Buchbinder SP.","Open Forum Infect Dis. 2018 May 4;5(6):ofy099. doi: 10.1093/ofid/ofy099. eCollection 2018 Jun.","Spinelli MA","Open Forum Infect Dis","2018","2018/07/07","PMC6016415","","10.1093/ofid/ofy099"
"32048078","Understanding PrEP Persistence: Provider and Patient Perspectives","Laborde ND, Kinley PM, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, Buchbinder SP.","AIDS Behav. 2020 Sep;24(9):2509-2519. doi: 10.1007/s10461-020-02807-3.","Laborde ND","AIDS Behav","2020","2020/02/13","PMC8054778","NIHMS1688187","10.1007/s10461-020-02807-3"
"20690259","HIV/AIDS-related stigma and discrimination in Nigeria: review of research studies and future directions for prevention strategies","Monjok E, Smesny A, Essien EJ.","Afr J Reprod Health. 2009 Sep;13(3):21-35.","Monjok E","Afr J Reprod Health","2009","2010/08/10","PMC2919838","NIHMS144303",""
"7818808","Prevention of HIV infection","Choi KH, Coates TJ.","AIDS. 1994 Oct;8(10):1371-89. doi: 10.1097/00002030-199410000-00003.","Choi KH","AIDS","1994","1994/10/01","","","10.1097/00002030-199410000-00003"
"31644481","Long-acting injectable cabotegravir for the prevention of HIV infection","Clement ME, Kofron R, Landovitz RJ.","Curr Opin HIV AIDS. 2020 Jan;15(1):19-26. doi: 10.1097/COH.0000000000000597.","Clement ME","Curr Opin HIV AIDS","2020","2019/10/24","PMC7382946","NIHMS1575634","10.1097/COH.0000000000000597"
"3331119","AIDS dementia: a review of the literature","Perry S, Marotta RF.","Alzheimer Dis Assoc Disord. 1987;1(4):221-35. doi: 10.1097/00002093-198701040-00002.","Perry S","Alzheimer Dis Assoc Disord","1987","1987/01/01","","","10.1097/00002093-198701040-00002"
"30649635","Experiences of Anticipated and Enacted Pre-exposure Prophylaxis (PrEP) Stigma Among Latino MSM in Los Angeles","Brooks RA, Landrian A, Nieto O, Fehrenbacher A.","AIDS Behav. 2019 Jul;23(7):1964-1973. doi: 10.1007/s10461-019-02397-9.","Brooks RA","AIDS Behav","2019","2019/01/17","PMC6571053","NIHMS1518895","10.1007/s10461-019-02397-9"
"33617771","The persistent and evolving HIV epidemic in American men who have sex with men","Mayer KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, Mena L, Reisner S, Daskalakis D, Safren SA, Beyrer C, Sullivan PS.","Lancet. 2021 Mar 20;397(10279):1116-1126. doi: 10.1016/S0140-6736(21)00321-4. Epub 2021 Feb 19.","Mayer KH","Lancet","2021","2021/02/22","PMC9639667","NIHMS1840449","10.1016/S0140-6736(21)00321-4"
"30993479","Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color","Wood S, Gross R, Shea JA, Bauermeister JA, Franklin J, Petsis D, Swyryn M, Lalley-Chareczko L, Koenig HC, Dowshen N.","AIDS Behav. 2019 Oct;23(10):2719-2729. doi: 10.1007/s10461-019-02502-y.","Wood S","AIDS Behav","2019","2019/04/18","PMC6790163","NIHMS1527152","10.1007/s10461-019-02502-y"
"33216244","Tailored HIV Pre-exposure Prophylaxis (PrEP) Intervention Needs from a Latent Class Analysis Among U.S. Healthcare Providers","John SA, Walsh JL, Pleuhs B, Wesche R, Quinn KG, Petroll AE.","AIDS Behav. 2021 Jun;25(6):1751-1760. doi: 10.1007/s10461-020-03105-8. Epub 2020 Nov 20.","John SA","AIDS Behav","2021","2020/11/20","PMC8084873","NIHMS1648826","10.1007/s10461-020-03105-8"
"26491256","Maraviroc: a review of its use in HIV infection and beyond","Woollard SM, Kanmogne GD.","Drug Des Devel Ther. 2015 Oct 1;9:5447-68. doi: 10.2147/DDDT.S90580. eCollection 2015.","Woollard SM","Drug Des Devel Ther","2015","2015/10/23","PMC4598208","","10.2147/DDDT.S90580"
"9336715","Psychobiology of HIV infection","Cole SW, Kemeny ME.","Crit Rev Neurobiol. 1997;11(4):289-321. doi: 10.1615/critrevneurobiol.v11.i4.30.","Cole SW","Crit Rev Neurobiol","1997","1997/01/01","","","10.1615/critrevneurobiol.v11.i4.30"
"24679634","HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research","Escudero DJ, Lurie MN, Kerr T, Howe CJ, Marshall BD.","J Int AIDS Soc. 2014 Mar 27;17(1):18899. doi: 10.7448/IAS.17.1.18899. eCollection 2014.","Escudero DJ","J Int AIDS Soc","2014","2014/04/01","PMC3969508","","10.7448/IAS.17.1.18899"
"30332309","PrEP Continuation, HIV and STI Testing Rates, and Delivery of Preventive Care in a Clinic-Based Cohort","Hevey MA, Walsh JL, Petroll AE.","AIDS Educ Prev. 2018 Oct;30(5):393-405. doi: 10.1521/aeap.2018.30.5.393.","Hevey MA","AIDS Educ Prev","2018","2018/10/18","PMC6535209","NIHMS1022128","10.1521/aeap.2018.30.5.393"
"7795068","Cytomegalovirus infections of the nervous system in patients with AIDS","McCutchan JA.","Clin Infect Dis. 1995 Apr;20(4):747-54. doi: 10.1093/clinids/20.4.747.","McCutchan JA","Clin Infect Dis","1995","1995/04/01","","","10.1093/clinids/20.4.747"
"30874995","Racial and Ethnic Disparities in HIV Pre-exposure Prophylaxis Awareness Among Men Who have Sex with Men","Raifman J, Dean LT, Montgomery MC, Almonte A, Arrington-Sanders R, Stein MD, Nunn AS, Sosnowy CD, Chan PA.","AIDS Behav. 2019 Oct;23(10):2706-2709. doi: 10.1007/s10461-019-02462-3.","Raifman J","AIDS Behav","2019","2019/03/16","PMC6744997","NIHMS1524002","10.1007/s10461-019-02462-3"
"31401755","HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture","Hu G, Niu F, Liao K, Periyasamy P, Sil S, Liu J, Dravid SM, Buch S.","J Neuroimmune Pharmacol. 2020 Sep;15(3):538-553. doi: 10.1007/s11481-019-09869-8. Epub 2019 Aug 10.","Hu G","J Neuroimmune Pharmacol","2020","2019/08/12","PMC7008083","NIHMS1537055","10.1007/s11481-019-09869-8"
"30689766","US Guideline Criteria for Human Immunodeficiency Virus Preexposure Prophylaxis: Clinical Considerations and Caveats","Calabrese SK, Krakower DS, Willie TC, Kershaw TS, Mayer KH.","Clin Infect Dis. 2019 Aug 16;69(5):884-889. doi: 10.1093/cid/ciz046.","Calabrese SK","Clin Infect Dis","2019","2019/01/29","PMC7320075","","10.1093/cid/ciz046"
"26895248","Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages","Hollenbaugh JA, Montero C, Schinazi RF, Munger J, Kim B.","Virology. 2016 Apr;491:106-14. doi: 10.1016/j.virol.2016.01.023. Epub 2016 Feb 16.","Hollenbaugh JA","Virology","2016","2016/02/20","PMC4834987","NIHMS777263","10.1016/j.virol.2016.01.023"
"28256421","Improving HIV prevention and care for African GBMSM","Graham SM, Harper GW.","Lancet HIV. 2017 Jun;4(6):e234-e236. doi: 10.1016/S2352-3018(17)30020-6. Epub 2017 Mar 1.","Graham SM","Lancet HIV","2017","2017/03/04","","","10.1016/S2352-3018(17)30020-6"
"16034275","Youths and HIV/AIDS: psychiatry's role in a changing epidemic","Donenberg GR, Pao M.","J Am Acad Child Adolesc Psychiatry. 2005 Aug;44(8):728-47. doi: 10.1097/01.chi.0000166381.68392.02.","Donenberg GR","J Am Acad Child Adolesc Psychiatry","2005","2005/07/22","PMC1634829","NIHMS4399","10.1097/01.chi.0000166381.68392.02"
"35135437","Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents","LoVette A, Kuo C, Giovenco D, Hoare J, Underhill K, Operario D.","SAHARA J. 2022 Dec;19(1):1-7. doi: 10.1080/17290376.2021.2016479.","LoVette A","SAHARA J","2022","2022/02/09","PMC8843204","","10.1080/17290376.2021.2016479"
"30796608","Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART?","O'Malley G, Barnabee G, Mugwanya K.","Curr HIV/AIDS Rep. 2019 Apr;16(2):141-150. doi: 10.1007/s11904-019-00437-6.","O'Malley G","Curr HIV/AIDS Rep","2019","2019/02/24","PMC6469867","","10.1007/s11904-019-00437-6"
"33311790","Are We Prescribing Enough HIV Pre-Exposure Prophylaxis in Missouri?: A Cross-Sectional Study at University of Missouri Health Care","Abu-Khalaf S, Dent J, Teti M, Dandachi D.","Mo Med. 2020 Nov-Dec;117(6):563-568.","Abu-Khalaf S","Mo Med","2020","2020/12/14","PMC7721420","",""
"28132744","Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis","Wood SM, Lee S, Barg FK, Castillo M, Dowshen N.","J Adolesc Health. 2017 May;60(5):549-555. doi: 10.1016/j.jadohealth.2016.12.004. Epub 2017 Jan 26.","Wood SM","J Adolesc Health","2017","2017/01/31","PMC5401785","NIHMS837300","10.1016/j.jadohealth.2016.12.004"
"19768553","CNS inflammation and macrophage/microglial biology associated with HIV-1 infection","Yadav A, Collman RG.","J Neuroimmune Pharmacol. 2009 Dec;4(4):430-47. doi: 10.1007/s11481-009-9174-2. Epub 2009 Sep 19.","Yadav A","J Neuroimmune Pharmacol","2009","2009/09/22","PMC5935112","NIHMS963676","10.1007/s11481-009-9174-2"
"36225150","Improving the HIV response for transgender populations: evidence to inform action","Poteat T, Phanuphak N, Grinsztejn B, Reisner SL.","J Int AIDS Soc. 2022 Oct;25 Suppl 5(Suppl 5):e25993. doi: 10.1002/jia2.25993.","Poteat T","J Int AIDS Soc","2022","2022/10/13","PMC9556998","","10.1002/jia2.25993"
"38411842","HIV-1 Myeloid Reservoirs - Contributors to Viral Persistence and Pathogenesis","Ferreira EA, Clements JE, Veenhuis RT.","Curr HIV/AIDS Rep. 2024 Apr;21(2):62-74. doi: 10.1007/s11904-024-00692-2. Epub 2024 Feb 27.","Ferreira EA","Curr HIV/AIDS Rep","2024","2024/02/27","","","10.1007/s11904-024-00692-2"
"31194291","PrEP interest and HIV-1 incidence among MSM and transgender women in coastal Kenya","Kimani M, van der Elst EM, Chiro O, Oduor C, Wahome E, Kazungu W, Shally M, Rinke de Wit TF, Graham SM, Operario D, Sanders EJ.","J Int AIDS Soc. 2019 Jun;22(6):e25323. doi: 10.1002/jia2.25323.","Kimani M","J Int AIDS Soc","2019","2019/06/14","PMC6563853","","10.1002/jia2.25323"
"20419478","Health and treatment implications of food insufficiency among people living with HIV/AIDS, Atlanta, Georgia","Kalichman SC, Cherry C, Amaral C, White D, Kalichman MO, Pope H, Swetsze C, Jones M, Macy R.","J Urban Health. 2010 Jul;87(4):631-41. doi: 10.1007/s11524-010-9446-4.","Kalichman SC","J Urban Health","2010","2010/04/27","PMC2900577","","10.1007/s11524-010-9446-4"
"31792704","""Getting to Zero"" Among Men Who Have Sex with Men in China: a Review of the HIV Care Continuum","Ritchwood TD, He J, Smith MK, Tang W, Ong JJ, Oduro A, Ntlapo N, Tucker JD.","Curr HIV/AIDS Rep. 2019 Dec;16(6):431-438. doi: 10.1007/s11904-019-00472-3.","Ritchwood TD","Curr HIV/AIDS Rep","2019","2019/12/04","PMC7163396","NIHMS1544987","10.1007/s11904-019-00472-3"
"28389443","Emerging opportunities and challenges for HIV prevention, treatment and care for MSM in the former Soviet Union and other post-communist states in Eastern Europe","Amirkhanian YA.","Sex Transm Infect. 2017 Aug;93(5):305-306. doi: 10.1136/sextrans-2016-052671. Epub 2017 Apr 7.","Amirkhanian YA","Sex Transm Infect","2017","2017/04/09","PMC5522349","NIHMS863922","10.1136/sextrans-2016-052671"
"14595004","Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection","Persidsky Y, Gendelman HE.","J Leukoc Biol. 2003 Nov;74(5):691-701. doi: 10.1189/jlb.0503205.","Persidsky Y","J Leukoc Biol","2003","2003/11/05","","","10.1189/jlb.0503205"
"19932385","Neurologic presentations of AIDS","Singer EJ, Valdes-Sueiras M, Commins D, Levine A.","Neurol Clin. 2010 Feb;28(1):253-75. doi: 10.1016/j.ncl.2009.09.018.","Singer EJ","Neurol Clin","2010","2009/11/26","PMC2806427","NIHMS166363","10.1016/j.ncl.2009.09.018"
"25045996","Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges","McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE.","AIDS Patient Care STDS. 2014 Sep;28(9):462-74. doi: 10.1089/apc.2013.0302. Epub 2014 Jul 21.","McMahon JM","AIDS Patient Care STDS","2014","2014/07/22","PMC4135325","","10.1089/apc.2013.0302"
"27896552","Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs","Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O.","AIDS Behav. 2017 Apr;21(4):1025-1033. doi: 10.1007/s10461-016-1612-6.","Edelman EJ","AIDS Behav","2017","2016/11/30","PMC5344709","NIHMS829554","10.1007/s10461-016-1612-6"
"27885552","PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists","Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA.","AIDS Behav. 2017 May;21(5):1256-1267. doi: 10.1007/s10461-016-1625-1.","Petroll AE","AIDS Behav","2017","2016/11/26","PMC5500978","NIHMS863927","10.1007/s10461-016-1625-1"
"34370571","Primary Care Providers' Knowledge, Attitudes, and Beliefs About HIV Pre-Exposure Prophylaxis (PrEP): Informing Network-Based Interventions","Storholm ED, Ober AJ, Mizel ML, Matthews L, Sargent M, Todd I, Zajdman D, Green H.","AIDS Educ Prev. 2021 Aug;33(4):325-344. doi: 10.1521/aeap.2021.33.4.325.","Storholm ED","AIDS Educ Prev","2021","2021/08/09","PMC8559721","NIHMS1749401","10.1521/aeap.2021.33.4.325"
"15075496","HIV, psychosis and aging: past, present and future","Dolder CR, Patterson TL, Jeste DV.","AIDS. 2004 Jan 1;18 Suppl 1:S35-42.","Dolder CR","AIDS","2004","2004/04/13","","",""
"23253768","Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine","Edelman EJ, Fiellin DA.","Am J Prev Med. 2013 Jan;44(1 Suppl 2):S86-90. doi: 10.1016/j.amepre.2012.09.035.","Edelman EJ","Am J Prev Med","2013","2012/12/21","PMC3645931","NIHMS459494","10.1016/j.amepre.2012.09.035"
"36094635","Patterns of Pre-exposure Prophylaxis (PrEP) Use in a Population Accessing PrEP in Jackson, Mississippi","Chase E, Mena L, Johnson KL, Prather M, Khosropour CM.","AIDS Behav. 2023 Apr;27(4):1082-1090. doi: 10.1007/s10461-022-03845-9. Epub 2022 Sep 12.","Chase E","AIDS Behav","2023","2022/09/12","PMC9465129","","10.1007/s10461-022-03845-9"
"26334052","No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting","Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB.","Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.","Volk JE","Clin Infect Dis","2015","2015/09/04","PMC4809999","","10.1093/cid/civ778"
"33634354","HIV Prevention Among Cisgender Men Who have Sex with Transgender Women","Poteat T, Cooney E, Malik M, Restar A, Dangerfield DT 2nd, White J.","AIDS Behav. 2021 Aug;25(8):2325-2335. doi: 10.1007/s10461-021-03194-z. Epub 2021 Feb 25.","Poteat T","AIDS Behav","2021","2021/02/26","PMC8222096","NIHMS1684668","10.1007/s10461-021-03194-z"
"22076814","CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis","Ansari AW, Heiken H, Meyer-Olson D, Schmidt RE.","Eur J Immunol. 2011 Dec;41(12):3412-8. doi: 10.1002/eji.201141676. Epub 2011 Nov 10.","Ansari AW","Eur J Immunol","2011","2011/11/15","","","10.1002/eji.201141676"
"26143247","Demographic Differences in PrEP-Related Stereotypes: Implications for Implementation","Golub SA, Gamarel KE, Surace A.","AIDS Behav. 2017 May;21(5):1229-1235. doi: 10.1007/s10461-015-1129-4.","Golub SA","AIDS Behav","2017","2015/07/06","PMC4701641","NIHMS705548","10.1007/s10461-015-1129-4"
"38529284","Oxidative phosphorylation in HIV-1 infection: impacts on cellular metabolism and immune function","Rodriguez NR, Fortune T, Hegde E, Weinstein MP, Keane AM, Mangold JF, Swartz TH.","Front Immunol. 2024 Mar 11;15:1360342. doi: 10.3389/fimmu.2024.1360342. eCollection 2024.","Rodriguez NR","Front Immunol","2024","2024/03/26","PMC10962326","","10.3389/fimmu.2024.1360342"
"32300991","HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers","John SA, Quinn KG, Pleuhs B, Walsh JL, Petroll AE.","AIDS Behav. 2020 Nov;24(11):3124-3131. doi: 10.1007/s10461-020-02866-6.","John SA","AIDS Behav","2020","2020/04/18","PMC7508835","NIHMS1606085","10.1007/s10461-020-02866-6"
"26091454","HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China","Tang Z, Lan G, Chen YQ, Zhu Q, Yang X, Shen Z, Chen Y, Zhang H, Kan W, Xing H, Ruan Y, Shao Y.","Medicine (Baltimore). 2015 Jun;94(24):e902. doi: 10.1097/MD.0000000000000902.","Tang Z","Medicine (Baltimore)","2015","2015/06/20","PMC4616551","","10.1097/MD.0000000000000902"
"26198351","PrEP Implementation Science: State-of-the-Art and Research Agenda","Cáceres CF, Mayer KH, Baggaley R, O'Reilly KR.","J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20527. doi: 10.7448/IAS.18.4.20527. eCollection 2015.","Cáceres CF","J Int AIDS Soc","2015","2015/07/23","PMC4581083","","10.7448/IAS.18.4.20527"
"33483897","The Impact of a Mobile Gaming Intervention to Increase Adherence to Pre-exposure Prophylaxis","Whiteley L, Craker L, Haubrick KK, Arnold T, Mena L, Olsen E, Brown LK.","AIDS Behav. 2021 Jun;25(6):1884-1889. doi: 10.1007/s10461-020-03118-3. Epub 2021 Jan 22.","Whiteley L","AIDS Behav","2021","2021/01/23","PMC8085097","NIHMS1686984","10.1007/s10461-020-03118-3"
"32109141","Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review","Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA.","AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28.","Pleuhs B","AIDS Patient Care STDS","2020","2020/02/29","PMC7087402","","10.1089/apc.2019.0189"
"31609925","PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples","Gilbert HN, Wyatt MA, Pisarski EE, Muwonge TR, Heffron R, Katabira ET, Celum CL, Baeten JM, Haberer JE, Ware NC.","J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):265-274. doi: 10.1097/QAI.0000000000002139.","Gilbert HN","J Acquir Immune Defic Syndr","2019","2019/10/15","PMC6812551","NIHMS1534875","10.1097/QAI.0000000000002139"
"34669062","Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review","Zhao A, Dangerfield DT 2nd, Nunn A, Patel R, Farley JE, Ugoji CC, Dean LT.","AIDS Behav. 2022 May;26(5):1377-1392. doi: 10.1007/s10461-021-03494-4. Epub 2021 Oct 20.","Zhao A","AIDS Behav","2022","2021/10/20","PMC8527816","","10.1007/s10461-021-03494-4"
"26633638","Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice","Haberer JE.","Curr Opin HIV AIDS. 2016 Jan;11(1):10-7. doi: 10.1097/COH.0000000000000220.","Haberer JE","Curr Opin HIV AIDS","2016","2015/12/04","PMC4801217","NIHMS755169","10.1097/COH.0000000000000220"
"1506505","Psychological interventions with AIDS and HIV: prevention and treatment","Kelly JA, Murphy DA.","J Consult Clin Psychol. 1992 Aug;60(4):576-85. doi: 10.1037//0022-006x.60.4.576.","Kelly JA","J Consult Clin Psychol","1992","1992/08/01","","","10.1037//0022-006x.60.4.576"
"24719201","Tensions between the epidemiology and psychology of HIV risk: implications for pre-exposure prophylaxis","Golub SA.","AIDS Behav. 2014 Sep;18(9):1686-93. doi: 10.1007/s10461-014-0770-7.","Golub SA","AIDS Behav","2014","2014/04/11","PMC4127100","NIHMS584524","10.1007/s10461-014-0770-7"
"26198345","Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress","Mayer KH, Hosek S, Cohen S, Liu A, Pickett J, Warren M, Krakower D, Grant R.","J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):19980. doi: 10.7448/IAS.18.4.19980. eCollection 2015.","Mayer KH","J Int AIDS Soc","2015","2015/07/23","PMC4509893","","10.7448/IAS.18.4.19980"
"33678712","Awareness of and Interest in Pre-Exposure Prophylaxis among Patients Receiving Services at Public Sexually Transmitted Disease Clinics in an Urban Setting","Yang C, Johnsen L, Thimm M, Tuddenham S, Rosecrans A, Davey-Rothwell M, Ghanem K, Chaulk P, Olthoff G, Greenbaum A, Page KR.","J Health Care Poor Underserved. 2021;32(1):537-549. doi: 10.1353/hpu.2021.0039.","Yang C","J Health Care Poor Underserved","2021","2021/03/08","PMC8627588","NIHMS1756672","10.1353/hpu.2021.0039"
"29168695","Tenofovir disoproxil fumarate as pre-exposure prophylaxis for HIV prevention in women with osteoporosis: a case report and review of the literature","Patel RR, Presti R, Harrison LC, Powderly WG, Chan PA.","Antivir Ther. 2018;23(4):379-382. doi: 10.3851/IMP3208.","Patel RR","Antivir Ther","2018","2017/11/24","PMC6003884","NIHMS972723","10.3851/IMP3208"
"31675786","Cost-Effectiveness of a Statewide Pre-Exposure Prophylaxis Program for Gay, Bisexual, and Other Men Who Have Sex with Men","Goedel WC, Chan PA, King MRF, Prosperi MCF, Marshall BDL, Galárraga O.","R I Med J (2013). 2019 Nov 1;102(9):36-39.","Goedel WC","R I Med J (2013)","2019","2019/11/03","PMC7461153","NIHMS1621489",""
"33899944","Human immunodeficiency virus-1/simian immunodeficiency virus infection induces opening of pannexin-1 channels resulting in neuronal synaptic compromise: A novel therapeutic opportunity to prevent NeuroHIV","Gorska AM, Donoso M, Valdebenito S, Prideaux B, Queen S, Scemes E, Clements J, Eugenin E.","J Neurochem. 2021 Jul;158(2):500-521. doi: 10.1111/jnc.15374. Epub 2021 May 9.","Gorska AM","J Neurochem","2021","2021/04/26","","","10.1111/jnc.15374"
"26633637","Welcome to the preexposure prophylaxis revolution","Baeten J, McCormack S.","Curr Opin HIV AIDS. 2016 Jan;11(1):1-2. doi: 10.1097/COH.0000000000000225.","Baeten J","Curr Opin HIV AIDS","2016","2015/12/04","","","10.1097/COH.0000000000000225"
"33633031","Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male Youth","Montgomery ET, Browne EN, Atujuna M, Boeri M, Mansfield C, Sindelo S, Hartmann M, Ndwayana S, Bekker LG, Minnis AM.","J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):928-936. doi: 10.1097/QAI.0000000000002670.","Montgomery ET","J Acquir Immune Defic Syndr","2021","2021/02/26","PMC8192422","NIHMS1675476","10.1097/QAI.0000000000002670"
"20418131","The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome","Fletcher NF, Meeker RB, Hudson LC, Callanan JJ.","Vet J. 2011 Jun;188(3):260-9. doi: 10.1016/j.tvjl.2010.03.022. Epub 2010 Apr 24.","Fletcher NF","Vet J","2011","2010/04/27","PMC3051004","NIHMS245032","10.1016/j.tvjl.2010.03.022"
"29257911","Body/Selves and Beyond: Men's Narratives of Sexual Behavior on PrEP","Hughes SD, Sheon N, Andrew EVW, Cohen SE, Doblecki-Lewis S, Liu AY.","Med Anthropol. 2018 Jul;37(5):387-400. doi: 10.1080/01459740.2017.1416608. Epub 2018 Jan 19.","Hughes SD","Med Anthropol","2018","2017/12/20","PMC6136979","NIHMS1500618","10.1080/01459740.2017.1416608"
"35904695","Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review","Kiptinness C, Kuo AP, Reedy AM, Johnson CC, Ngure K, Wagner AD, Ortblad KF.","Curr HIV/AIDS Rep. 2022 Oct;19(5):394-408. doi: 10.1007/s11904-022-00617-x. Epub 2022 Jul 29.","Kiptinness C","Curr HIV/AIDS Rep","2022","2022/07/29","PMC9334974","","10.1007/s11904-022-00617-x"
"31272495","HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya","Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, Donnell D, Mugo NR, Baeten JM, Ngure K.","Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.","Ortblad KF","Trials","2019","2019/07/06","PMC6610957","","10.1186/s13063-019-3521-2"
"24003891","Social and policy dimensions of HIV and AIDS in Vietnam. Introduction","Giang le M, Hirsch JS, Parker RG, Vasquez EE.","Glob Public Health. 2013;8 Suppl 1(0 1):S1-6. doi: 10.1080/17441692.2013.797484.","Giang le M","Glob Public Health","2013","2013/09/06","PMC4520300","NIHMS709494","10.1080/17441692.2013.797484"
"1997729","Microglia in human disease, with an emphasis on acquired immune deficiency syndrome","Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF.","Lab Invest. 1991 Feb;64(2):135-56.","Dickson DW","Lab Invest","1991","1991/02/01","","",""
"37716712","Making a Choice With Your Adolescent: Next-Generation HIV Pre-Exposure Prophylaxis and Parents of Sexual and Gender Minority Adolescents in the United States","Rusley JC, Valente PK, Chan PA.","J Adolesc Health. 2023 Oct;73(4):611-613. doi: 10.1016/j.jadohealth.2023.07.003.","Rusley JC","J Adolesc Health","2023","2023/09/16","","","10.1016/j.jadohealth.2023.07.003"
"37079900","The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya","Omollo V, Asewe M, Mogere P, Maina G, Kuo AP, Odoyo J, Oware K, Baeten JM, Kohler P, Owens T, Bukusi EA, Ngure K, Ortblad KF.","J Acquir Immune Defic Syndr. 2023 Aug 15;93(5):379-386. doi: 10.1097/QAI.0000000000003208.","Omollo V","J Acquir Immune Defic Syndr","2023","2023/04/20","PMC10337311","NIHMS1891288","10.1097/QAI.0000000000003208"
"25139057","A multilevel understanding of HIV/AIDS disease burden among African American women","Brawner BM.","J Obstet Gynecol Neonatal Nurs. 2014 Sep-Oct;43(5):633-643. doi: 10.1111/1552-6909.12481. Epub 2014 Aug 19.","Brawner BM","J Obstet Gynecol Neonatal Nurs","2014","2014/08/21","PMC4772147","NIHMS756077","10.1111/1552-6909.12481"
"22972843","Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men","Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, McMahan V, Bushman LR, Casapía M, Montoya-Herrera O, Veloso VG, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Grant RM; iPrEx Study Team.","Sci Transl Med. 2012 Sep 12;4(151):151ra125. doi: 10.1126/scitranslmed.3004006.","Anderson PL","Sci Transl Med","2012","2012/09/14","PMC3721979","NIHMS485154","10.1126/scitranslmed.3004006"
"32638629","Masculine ideology and Black men who have sex with men's interest in HIV pre-exposure prophylaxis (PrEP)","Driver R, Allen AM, Finneran S, Maksut JL, Eaton LA, Kalichman SC.","J Health Psychol. 2021 Dec;26(14):2908-2920. doi: 10.1177/1359105320941236. Epub 2020 Jul 8.","Driver R","J Health Psychol","2021","2020/07/09","","","10.1177/1359105320941236"
"8423065","Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease","Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C.","Glia. 1993 Jan;7(1):75-83. doi: 10.1002/glia.440070113.","Dickson DW","Glia","1993","1993/01/01","","","10.1002/glia.440070113"
"19415552","Adapting effective narrative-based HIV-prevention interventions to increase minorities' engagement in HIV/AIDS services","Berkley-Patton J, Goggin K, Liston R, Bradley-Ewing A, Neville S.","Health Commun. 2009 Apr;24(3):199-209. doi: 10.1080/10410230902804091.","Berkley-Patton J","Health Commun","2009","2009/05/06","PMC2746743","NIHMS112980","10.1080/10410230902804091"
"16670228","HIV Infection and AIDS in the Deep South","Reif S, Geonnotti KL, Whetten K.","Am J Public Health. 2006 Jun;96(6):970-3. doi: 10.2105/AJPH.2005.063149. Epub 2006 May 2.","Reif S","Am J Public Health","2006","2006/05/04","PMC1470626","","10.2105/AJPH.2005.063149"
"28819214","HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy","Gupta MK, Kaminski R, Mullen B, Gordon J, Burdo TH, Cheung JY, Feldman AM, Madesh M, Khalili K.","Sci Rep. 2017 Aug 17;7(1):8572. doi: 10.1038/s41598-017-08736-x.","Gupta MK","Sci Rep","2017","2017/08/19","PMC5561171","","10.1038/s41598-017-08736-x"
"29847480","HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood","Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, Willie TC, Caldwell A, Kaplan C, Kershaw TS.","J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):46-53. doi: 10.1097/QAI.0000000000001762.","Calabrese SK","J Acquir Immune Defic Syndr","2018","2018/05/31","PMC6092222","NIHMS967591","10.1097/QAI.0000000000001762"
"32109293","Frequency and Predictors of Tenofovir-diphosphate Detection Among Young Kenyan Women in a Real-world Pre-exposure Prophylaxis Implementation Program","Pintye J, Kinuthia J, Abuna F, Mugwanya K, Lagat H, Dettinger JC, Odinga D, Sila J, Anderson PL, John-Stewart G, Baeten JM.","Clin Infect Dis. 2020 Dec 3;71(9):e509-e512. doi: 10.1093/cid/ciaa181.","Pintye J","Clin Infect Dis","2020","2020/02/29","PMC7713682","","10.1093/cid/ciaa181"
"29524096","Strength of Implementation Intentions to Use Condoms Among Men Who Have Sex with Men","Nydegger LA, Walsh JL.","AIDS Behav. 2018 Nov;22(11):3491-3499. doi: 10.1007/s10461-018-2079-4.","Nydegger LA","AIDS Behav","2018","2018/03/11","PMC6129435","NIHMS949991","10.1007/s10461-018-2079-4"
"12453805","Allocating HIV-prevention resources: balancing efficiency and equity","Kaplan EH, Merson MH.","Am J Public Health. 2002 Dec;92(12):1905-7. doi: 10.2105/ajph.92.12.1905.","Kaplan EH","Am J Public Health","2002","2002/11/28","PMC1447350","","10.2105/ajph.92.12.1905"
"1925601","Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection","Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M.","Science. 1991 Oct 18;254(5030):423-7. doi: 10.1126/science.1925601.","Bukrinsky MI","Science","1991","1991/10/18","PMC9524215","NIHMS1836933","10.1126/science.1925601"
"15611202","AIDS-related stigma and social interaction: Puerto Ricans living with HIV/AIDS","Varas-Díaz N, Serrano-García I, Toro-Alfonso J.","Qual Health Res. 2005 Feb;15(2):169-87. doi: 10.1177/1049732304272059.","Varas-Díaz N","Qual Health Res","2005","2004/12/22","","","10.1177/1049732304272059"
"18519882","Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions","Kalichman SC.","Psychosom Med. 2008 Jun;70(5):593-7. doi: 10.1097/PSY.0b013e3181773bce. Epub 2008 Jun 2.","Kalichman SC","Psychosom Med","2008","2008/06/04","","","10.1097/PSY.0b013e3181773bce"
"25124457","Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships","Gamarel KE, Golub SA.","Ann Behav Med. 2015 Apr;49(2):177-86. doi: 10.1007/s12160-014-9646-3.","Gamarel KE","Ann Behav Med","2015","2014/08/16","PMC4329279","NIHMS617282","10.1007/s12160-014-9646-3"
"21424866","Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa","Choi Y, Townend J, Vincent T, Zaidi I, Sarge-Njie R, Jaye A, Clifford DB.","J Neurovirol. 2011 Apr;17(2):166-75. doi: 10.1007/s13365-011-0022-9. Epub 2011 Mar 22.","Choi Y","J Neurovirol","2011","2011/03/23","PMC4470556","NIHMS699866","10.1007/s13365-011-0022-9"
"30267365","Disclosure of HIV Serostatus and Pre-exposure Prophylaxis Use on Internet Hookup Sites Among Men Who have Sex with Men","Medina MM, Crowley C, Montgomery MC, Tributino A, Almonte A, Sowemimo-Coker G, Nunn A, Chan PA.","AIDS Behav. 2019 Jul;23(7):1681-1688. doi: 10.1007/s10461-018-2286-z.","Medina MM","AIDS Behav","2019","2018/09/30","PMC6438768","NIHMS1508402","10.1007/s10461-018-2286-z"
"18040840","Feline immunodeficiency virus neuropathogenesis: from cats to calcium","Meeker RB.","J Neuroimmune Pharmacol. 2007 Jun;2(2):154-70. doi: 10.1007/s11481-006-9045-z. Epub 2006 Nov 28.","Meeker RB","J Neuroimmune Pharmacol","2007","2007/11/28","PMC3166855","NIHMS306051","10.1007/s11481-006-9045-z"
"26034832","Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?","Carryl H, Swang M, Lawrence J, Curtis K, Kamboj H, Van Rompay KK, De Paris K, Burke MW.","ACS Chem Neurosci. 2015 Aug 19;6(8):1276-89. doi: 10.1021/acschemneuro.5b00044. Epub 2015 Jun 19.","Carryl H","ACS Chem Neurosci","2015","2015/06/03","PMC4545399","NIHMS700257","10.1021/acschemneuro.5b00044"
"23203364","HIV/AIDS and serious mental illness: a risky conclusion","Cournos F, Guimarães MD, Wainberg ML.","Psychiatr Serv. 2012 Dec;63(12):1261; author reply 1261-2. doi: 10.1176/appi.ps.631202.","Cournos F","Psychiatr Serv","2012","2012/12/04","PMC4112123","NIHMS587473","10.1176/appi.ps.631202"
"22333749","Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention","van der Straten A, Van Damme L, Haberer JE, Bangsberg DR.","AIDS. 2012 Apr 24;26(7):F13-9. doi: 10.1097/QAD.0b013e3283522272.","van der Straten A","AIDS","2012","2012/02/16","","","10.1097/QAD.0b013e3283522272"
"36112336","Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?","Parikh UM, Koss CA, Mellors JW.","Curr HIV/AIDS Rep. 2022 Oct;19(5):384-393. doi: 10.1007/s11904-022-00616-y. Epub 2022 Sep 16.","Parikh UM","Curr HIV/AIDS Rep","2022","2022/09/16","PMC9508028","","10.1007/s11904-022-00616-y"
"32207327","""Now that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?"" the condom quandary among PrEP users and health care providers in Kenya","Irungu EM, Ngure K, Mugwanya KK, Awuor M, Dollah A, Ongolly F, Mugo N, Bukusi E, Wamoni E, Odoyo J, Morton JF, Barnabee G, Mukui I, Baeten JM, O'Malley G; Partners Scale-Up Project Team.","AIDS Care. 2021 Jan;33(1):92-100. doi: 10.1080/09540121.2020.1744507. Epub 2020 Mar 24.","Irungu EM","AIDS Care","2021","2020/03/25","PMC7511416","NIHMS1578901","10.1080/09540121.2020.1744507"
"22943414","Annual Research Review: Mental health and resilience in HIV/AIDS-affected children-- a review of the literature and recommendations for future research","Betancourt TS, Meyers-Ohki SE, Charrow A, Hansen N.","J Child Psychol Psychiatry. 2013 Apr;54(4):423-44. doi: 10.1111/j.1469-7610.2012.02613.x. Epub 2012 Sep 4.","Betancourt TS","J Child Psychol Psychiatry","2013","2012/09/05","PMC3656822","NIHMS398459","10.1111/j.1469-7610.2012.02613.x"
"31295427","The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections","Bender AM, Simonetti FR, Kumar MR, Fray EJ, Bruner KM, Timmons AE, Tai KY, Jenike KM, Antar AAR, Liu PT, Ho YC, Raugi DN, Seydi M, Gottlieb GS, Okoye AA, Del Prete GQ, Picker LJ, Mankowski JL, Lifson JD, Siliciano JD, Laird GM, Barouch DH, Clements JE, Siliciano RF.","Cell Host Microbe. 2019 Jul 10;26(1):73-85.e4. doi: 10.1016/j.chom.2019.06.005.","Bender AM","Cell Host Microbe","2019","2019/07/12","PMC6724192","NIHMS1534124","10.1016/j.chom.2019.06.005"
"35190430","PrEP distribution in pharmacies: a systematic review","Kennedy CE, Yeh PT, Atkins K, Ferguson L, Baggaley R, Narasimhan M.","BMJ Open. 2022 Feb 21;12(2):e054121. doi: 10.1136/bmjopen-2021-054121.","Kennedy CE","BMJ Open","2022","2022/02/22","PMC8860049","","10.1136/bmjopen-2021-054121"
"34874976","Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection","Sharma V, Creegan M, Tokarev A, Hsu D, Slike BM, Sacdalan C, Chan P, Spudich S, Ananworanich J, Eller MA, Krebs SJ, Vasan S, Bolton DL; RV254/SEARCH010 and RV304/SEARCH013 Study Teams.","PLoS Pathog. 2021 Dec 7;17(12):e1010105. doi: 10.1371/journal.ppat.1010105. eCollection 2021 Dec.","Sharma V","PLoS Pathog","2021","2021/12/07","PMC8683024","","10.1371/journal.ppat.1010105"
"35316471","Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa","Beesham I, Dovel K, Mashele N, Bekker LG, Gorbach P, Coates TJ, Myer L, Joseph Davey DL.","AIDS Behav. 2022 Sep;26(9):3079-3087. doi: 10.1007/s10461-022-03652-2. Epub 2022 Mar 22.","Beesham I","AIDS Behav","2022","2022/03/22","PMC8938734","","10.1007/s10461-022-03652-2"
"10225826","Current concepts in human immunodeficiency virus infection and AIDS","Schwartz SA, Nair MP.","Clin Diagn Lab Immunol. 1999 May;6(3):295-305. doi: 10.1128/CDLI.6.3.295-305.1999.","Schwartz SA","Clin Diagn Lab Immunol","1999","1999/05/04","PMC103713","","10.1128/CDLI.6.3.295-305.1999"
"24965676","HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study","Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH.","AIDS Behav. 2014 Sep;18(9):1712-21. doi: 10.1007/s10461-014-0839-3.","Krakower D","AIDS Behav","2014","2014/06/27","PMC4127184","NIHMS609008","10.1007/s10461-014-0839-3"
"34240317","Qualitative Assessment of Barriers and Facilitators of PrEP Use Before and After Rollout of a PrEP Program for Priority Populations in South-central Uganda","Ddaaki W, Strömdahl S, Yeh PT, Rosen JG, Jackson J, Nakyanjo N, Kagaayi J, Kigozi G, Nakigozi G, Grabowski MK, Chang LW, Reynolds SJ, Nalugoda F, Ekström AM, Kennedy CE.","AIDS Behav. 2021 Nov;25(11):3547-3562. doi: 10.1007/s10461-021-03360-3. Epub 2021 Jul 9.","Ddaaki W","AIDS Behav","2021","2021/07/09","PMC8603943","NIHMS1754379","10.1007/s10461-021-03360-3"
"17589187","HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people","Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD.","AIDS. 2007 Jul 11;21(11):1415-22. doi: 10.1097/QAD.0b013e328220e71a.","Vitiello B","AIDS","2007","2007/06/26","","","10.1097/QAD.0b013e328220e71a"
"31707556","Demographic, Behavioral, and Geographic Differences Between Men, Transmen, and Transwomen Currently on PrEP, Former PrEP Users, and Those Having Never Used PrEP","Westmoreland DA, Pantalone DW, Patel VV, Hoover D, Nash D, Grov C.","AIDS Behav. 2020 May;24(5):1304-1311. doi: 10.1007/s10461-019-02722-2.","Westmoreland DA","AIDS Behav","2020","2019/11/11","PMC7162710","NIHMS1542549","10.1007/s10461-019-02722-2"
"34561792","Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting","Giovenco D, Kuo C, Underhill K, Hoare J, Operario D.","Arch Sex Behav. 2021 Oct;50(7):2921-2931. doi: 10.1007/s10508-021-02052-2. Epub 2021 Sep 24.","Giovenco D","Arch Sex Behav","2021","2021/09/25","PMC8744480","NIHMS1762199","10.1007/s10508-021-02052-2"
"33826022","Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives","Roche SD, Wairimu N, Mogere P, Kamolloh K, Odoyo J, Kwena ZA, Bukusi EA, Ngure K, Baeten JM, Ortblad KF.","AIDS Behav. 2021 Dec;25(12):3871-3882. doi: 10.1007/s10461-021-03229-5. Epub 2021 Apr 7.","Roche SD","AIDS Behav","2021","2021/04/07","PMC8602157","","10.1007/s10461-021-03229-5"
"20367240","Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain","Lamers SL, Salemi M, Galligan DC, Morris A, Gray R, Fogel G, Zhao L, McGrath MS.","J Neurovirol. 2010 May;16(3):230-41. doi: 10.3109/13550281003735709.","Lamers SL","J Neurovirol","2010","2010/04/07","PMC2994721","NIHMS225058","10.3109/13550281003735709"
"37415442","Acceptability and Comfort Regarding Remotely Delivered PrEP Services in Mississippi","Giorlando KK, Arnold T, Barnett AP, Leigland A, Whiteley L, Brock JB, Brown LK.","J Int Assoc Provid AIDS Care. 2023 Jan-Dec;22:23259582231186868. doi: 10.1177/23259582231186868.","Giorlando KK","J Int Assoc Provid AIDS Care","2023","2023/07/07","PMC10331183","","10.1177/23259582231186868"
"35703760","Strengthening HIV Prevention Services Through an Implementation Science Approach: Perspectives From the HIV Testers in Philadelphia","Wood SM, Meanley S, Bonett S, Torres ME, Watson DL, Williams JL, Brady KA, Bauermeister JA.","J Acquir Immune Defic Syndr. 2022 Jul 1;90(S1):S90-S97. doi: 10.1097/QAI.0000000000002969.","Wood SM","J Acquir Immune Defic Syndr","2022","2022/06/15","PMC9204788","NIHMS1791010","10.1097/QAI.0000000000002969"
"9697940","Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention","Kelly JA, Otto-Salaj LL, Sikkema KJ, Pinkerton SD, Bloom FR.","Health Psychol. 1998 Jul;17(4):310-9. doi: 10.1037//0278-6133.17.4.310.","Kelly JA","Health Psychol","1998","1998/08/11","","","10.1037//0278-6133.17.4.310"
"36807245","Condomless Sex Among HIV-affected AYA in an Era of Undetectable = Untransmittable and Pre-exposure Prophylaxis","Kluisza L, Attoh-Okine ND, Nguyen N, Robbins RN, Leu CS, Liotta L, Morrison C, Dolezal C, Remien RH, Wiznia A, Abrams EJ, Mellins CA.","AIDS Behav. 2023 Sep;27(9):2979-2987. doi: 10.1007/s10461-023-04020-4. Epub 2023 Feb 20.","Kluisza L","AIDS Behav","2023","2023/02/22","PMC10439969","NIHMS1876701","10.1007/s10461-023-04020-4"
"33535887","Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention","Jackson GY, Darlington CK, Van Tieu H, Brawner BM, Flores DD, Bannon JA, Davis A, Frye V, Chittamuru D, Gugerty P, Koblin BA, Teitelman AM.","Cult Health Sex. 2022 May;24(5):642-656. doi: 10.1080/13691058.2021.1877824. Epub 2021 Feb 4.","Jackson GY","Cult Health Sex","2022","2021/02/04","PMC8567214","NIHMS1722606","10.1080/13691058.2021.1877824"
"39272987","Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse","Annadurai N, Kanmogne GD.","Cells. 2024 Aug 24;13(17):1415. doi: 10.3390/cells13171415.","Annadurai N","Cells","2024","2024/09/14","PMC11393916","","10.3390/cells13171415"
"23903845","AIDS alters the commensal plasma virome","Li L, Deng X, Linsuwanon P, Bangsberg D, Bwana MB, Hunt P, Martin JN, Deeks SG, Delwart E.","J Virol. 2013 Oct;87(19):10912-5. doi: 10.1128/JVI.01839-13. Epub 2013 Jul 31.","Li L","J Virol","2013","2013/08/02","PMC3807392","","10.1128/JVI.01839-13"
"22999095","Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment","Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM; CHARTER Study Group.","Virology. 2012 Nov 25;433(2):498-505. doi: 10.1016/j.virol.2012.08.028. Epub 2012 Sep 20.","Hightower GK","Virology","2012","2012/09/25","PMC3466337","NIHMS405400","10.1016/j.virol.2012.08.028"
"34903055","Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation","Mohammadzadeh N, Roda W, Branton WG, Clain J, Rabezanahary H, Zghidi-Abouzid O, Gelman BB, Angel JB, Cohen EA, Gill MJ, Li M, Estaquier J, Power C.","mBio. 2021 Dec 21;12(6):e0278421. doi: 10.1128/mBio.02784-21. Epub 2021 Dec 14.","Mohammadzadeh N","mBio","2021","2021/12/14","PMC8669467","","10.1128/mBio.02784-21"
"29327091","Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP)","Underhill K, Guthrie KM, Colleran C, Calabrese SK, Operario D, Mayer KH.","Arch Sex Behav. 2018 Oct;47(7):2109-2121. doi: 10.1007/s10508-017-1100-8. Epub 2018 Jan 11.","Underhill K","Arch Sex Behav","2018","2018/01/13","PMC6041197","NIHMS934235","10.1007/s10508-017-1100-8"
"26092857","Safer Conception Strategies for HIV-Serodiscordant Couples: How Safe Is Safe Enough?","Ciaranello AL, Matthews LT.","J Infect Dis. 2015 Nov 15;212(10):1525-8. doi: 10.1093/infdis/jiv275. Epub 2015 Jun 19.","Ciaranello AL","J Infect Dis","2015","2015/06/21","PMC4621252","","10.1093/infdis/jiv275"
"34048328","Factors associated with awareness and use of pre-exposure prophylaxis (PrEP) among Black men who have sex with men with a recent STI diagnosis","Maksut JL, Eaton LA, Driver R, Knowles CM, Watson RJ.","Behav Med. 2021 Apr-Jun;47(2):161-169. doi: 10.1080/08964289.2019.1692776. Epub 2020 Jun 17.","Maksut JL","Behav Med","2021","2021/05/28","PMC8163996","NIHMS1546368","10.1080/08964289.2019.1692776"
"20492840","Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study","Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ.","J Clin Psychiatry. 2010 Jun;71(6):707-15. doi: 10.4088/JCP.09m05171bro. Epub 2010 May 4.","Rabkin JG","J Clin Psychiatry","2010","2010/05/25","PMC2892004","NIHMS127465","10.4088/JCP.09m05171bro"
"32844591","The importance of PrEP persistence in preventing HIV infections on PrEP","Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP.","J Int AIDS Soc. 2020 Aug;23(8):e25578. doi: 10.1002/jia2.25578.","Spinelli MA","J Int AIDS Soc","2020","2020/08/27","PMC7448189","","10.1002/jia2.25578"
"37196008","POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT)","Ridgway JP, Devlin SA, Friedman EE, Enaholo OE, Pyra M, Hirschhorn LR, Haider S, Ducheny K, Johnson AK.","PLoS One. 2023 May 17;18(5):e0285858. doi: 10.1371/journal.pone.0285858. eCollection 2023.","Ridgway JP","PLoS One","2023","2023/05/17","PMC10191268","","10.1371/journal.pone.0285858"
"25972502","Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach","Blashill AJ, Ehlinger PP, Mayer KH, Safren SA.","Clin Infect Dis. 2015 Jun 1;60 Suppl 3(Suppl 3):S187-90. doi: 10.1093/cid/civ111.","Blashill AJ","Clin Infect Dis","2015","2015/05/15","PMC4551106","","10.1093/cid/civ111"
"8267298","Central nervous system pathology in pediatric AIDS","Dickson DW, Llena JF, Nelson SJ, Weidenheim KM.","Ann N Y Acad Sci. 1993 Oct 29;693:93-106. doi: 10.1111/j.1749-6632.1993.tb26259.x.","Dickson DW","Ann N Y Acad Sci","1993","1993/10/29","","","10.1111/j.1749-6632.1993.tb26259.x"
"32860114","Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials","Wood SM, Morales KH, Metzger D, Davis A, Fiore D, Petsis D, Barnett K, Koenig HC, Dowshen N, Gross R, Frank I.","AIDS Behav. 2021 Feb;25(2):524-531. doi: 10.1007/s10461-020-03004-y.","Wood SM","AIDS Behav","2021","2020/08/30","PMC8546869","NIHMS1624727","10.1007/s10461-020-03004-y"
"26270688","Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation","Mayer KH, Krakower DS.","Clin Infect Dis. 2015 Nov 15;61(10):1598-600. doi: 10.1093/cid/civ665. Epub 2015 Aug 13.","Mayer KH","Clin Infect Dis","2015","2015/08/14","PMC4614415","","10.1093/cid/civ665"
"31584857","Potential Impact of Interventions to Enhance Retention in Care During Real-World HIV Pre-Exposure Prophylaxis Implementation","Chan PA, Goedel WC, Nunn AS, Sowemimo-Coker G, Galárraga O, Prosperi M, Patel R, Mena L, Montgomery MC, Marshall BDL.","AIDS Patient Care STDS. 2019 Oct;33(10):434-439. doi: 10.1089/apc.2019.0064.","Chan PA","AIDS Patient Care STDS","2019","2019/10/05","PMC6806311","","10.1089/apc.2019.0064"
"33791880","Acceptability, Appropriateness, and Preliminary Effects of the PrEP Diffusion Training for Lay HIV Workers: Increased PrEP Knowledge, Decreased Stigma, and Diffusion of Innovation","Wu Y, Yang G, Meyers K.","AIDS Behav. 2021 Oct;25(10):3413-3424. doi: 10.1007/s10461-021-03248-2. Epub 2021 Mar 31.","Wu Y","AIDS Behav","2021","2021/04/01","PMC8916091","NIHMS1691733","10.1007/s10461-021-03248-2"
"30953305","Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California : Mind the Gaps: Cobertura de recetas e incidencia de VIH entre pacientes recibiendo profilaxis pre-exposición de un centro de salud grande y federalmente calificado en Los Ángeles, CA","Shover CL, Shoptaw S, Javanbakht M, Lee SJ, Bolan RK, Cunningham NJ, Beymer MR, DeVost MA, Gorbach PM.","AIDS Behav. 2019 Oct;23(10):2730-2740. doi: 10.1007/s10461-019-02493-w.","Shover CL","AIDS Behav","2019","2019/04/07","PMC6863609","NIHMS1526454","10.1007/s10461-019-02493-w"
"32692101","HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States","Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH.","J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):437-442. doi: 10.1097/QAI.0000000000002403.","Sevelius JM","J Acquir Immune Defic Syndr","2020","2020/07/22","PMC7340231","","10.1097/QAI.0000000000002403"
"36219270","Challenges with PrEP Uptake and Adherence Among Gay, Bisexual, and Other Men Who Have Sex with Men in Kisumu, Kenya","Graham SM, Okall DO, Mehta SD, Obondi E, Ng'ety G, Ochieng E, Jadwin-Cakmak L, Amico KR, Harper GW, Bailey RC, Otieno FO.","AIDS Behav. 2023 Apr;27(4):1234-1247. doi: 10.1007/s10461-022-03860-w. Epub 2022 Oct 11.","Graham SM","AIDS Behav","2023","2022/10/11","PMC10036412","","10.1007/s10461-022-03860-w"
"2181004","Virology, immunology, and clinical course of HIV infection","McCutchan JA.","J Consult Clin Psychol. 1990 Feb;58(1):5-12. doi: 10.1037//0022-006x.58.1.5.","McCutchan JA","J Consult Clin Psychol","1990","1990/02/01","","","10.1037//0022-006x.58.1.5"
"33624193","Project SLIP: Implementation of a PrEP Screening and Linkage Intervention in Primary Care","Storholm ED, Siconolfi D, Huang W, Towner W, Grant DL, Martos A, Chang JM, Hechter R.","AIDS Behav. 2021 Aug;25(8):2348-2357. doi: 10.1007/s10461-021-03197-w. Epub 2021 Feb 24.","Storholm ED","AIDS Behav","2021","2021/02/24","PMC8556139","NIHMS1749402","10.1007/s10461-021-03197-w"
"36215734","Factors associated with suboptimal retention in HIV pre-exposure prophylaxis care among men who have sex with men","Rogers BG, Sosnowy C, Chan PA, Patel RR, Mena LA, Arnold T, Gomillia C, Zanowick-Marr A, Curoe K, Underwood A, Villalobos J, Chu C, Galipeau D, Montgomery M, Nunn AS.","AIDS Care. 2023 Apr;35(4):495-508. doi: 10.1080/09540121.2022.2129036. Epub 2022 Oct 10.","Rogers BG","AIDS Care","2023","2022/10/10","PMC10083191","NIHMS1853405","10.1080/09540121.2022.2129036"
"26293904","A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the ""Purview Paradox""","Hoffman S, Guidry JA, Collier KL, Mantell JE, Boccher-Lattimore D, Kaighobadi F, Sandfort TG.","J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):59-65. doi: 10.1177/2325957415600798. Epub 2015 Aug 20.","Hoffman S","J Int Assoc Provid AIDS Care","2016","2015/08/22","PMC4703503","NIHMS729543","10.1177/2325957415600798"
"16764941","Depression and suicidality in HIV/AIDS in China","Jin H, Hampton Atkinson J, Yu X, Heaton RK, Shi C, Marcotte TP, Young C, Sadek J, Wu Z, Grant I; HNRC China collaboration group.","J Affect Disord. 2006 Aug;94(1-3):269-75. doi: 10.1016/j.jad.2006.04.013. Epub 2006 Jun 9.","Jin H","J Affect Disord","2006","2006/06/13","","","10.1016/j.jad.2006.04.013"
"36371748","Impact of Homophobia and Racism on Comfort Receiving Pre-exposure Prophylaxis at Various Locations Among Black MSM in Mississippi","Haubrick KK, Whiteley L, Arnold T, Leigland A, Ward LM, Brock JB, Brown LK.","AIDS Behav. 2023 Jun;27(6):1870-1878. doi: 10.1007/s10461-022-03918-9. Epub 2022 Nov 13.","Haubrick KK","AIDS Behav","2023","2022/11/13","PMC10149555","NIHMS1854608","10.1007/s10461-022-03918-9"
"8543713","Increased attention to human sexuality can improve HIV-AIDS prevention efforts: key research issues and directions","Kelly JA, Kalichman SC.","J Consult Clin Psychol. 1995 Dec;63(6):907-18. doi: 10.1037//0022-006x.63.6.907.","Kelly JA","J Consult Clin Psychol","1995","1995/12/01","","","10.1037//0022-006x.63.6.907"
"28774464","Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives","Anderson AM, Schein TN, Kalapila A, Lai L, Waldrop-Valverde D, Moore RC, Franklin D, Letendre SL, Barnum SR.","J Neuroimmunol. 2017 Oct 15;311:35-39. doi: 10.1016/j.jneuroim.2017.07.014. Epub 2017 Jul 23.","Anderson AM","J Neuroimmunol","2017","2017/08/05","PMC5682931","NIHMS897134","10.1016/j.jneuroim.2017.07.014"
"8395480","Psychoneuroimmunological aspects of disease progression among women with human papillomavirus-associated cervical dysplasia and human immunodeficiency virus type 1 co-infection","Goodkin K, Antoni MH, Helder L, Sevin B.","Int J Psychiatry Med. 1993;23(2):119-48. doi: 10.2190/F8F0-4UK8-XV79-EC6G.","Goodkin K","Int J Psychiatry Med","1993","1993/01/01","","","10.2190/F8F0-4UK8-XV79-EC6G"
"31490343","Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya","Olilo WA, Petersen ML, Koss CA, Wafula E, Kwarisiima D, Kadede K, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Charlebois ED, Havlir DV, Ayieko J; SEARCH Collaboration.","J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):e50-e53. doi: 10.1097/QAI.0000000000002150.","Olilo WA","J Acquir Immune Defic Syndr","2019","2019/09/07","PMC6831040","","10.1097/QAI.0000000000002150"
"27558569","Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So?","Mayer KH, Krakower DS.","Clin Infect Dis. 2016 Dec 1;63(11):1505-1507. doi: 10.1093/cid/ciw582. Epub 2016 Aug 23.","Mayer KH","Clin Infect Dis","2016","2016/08/26","PMC5106609","","10.1093/cid/ciw582"
"18202907","The impact of medication regimen factors on adherence to chronic treatment: a review of literature","Ingersoll KS, Cohen J.","J Behav Med. 2008 Jun;31(3):213-24. doi: 10.1007/s10865-007-9147-y. Epub 2008 Jan 19.","Ingersoll KS","J Behav Med","2008","2008/01/19","PMC2868342","NIHMS200469","10.1007/s10865-007-9147-y"
"16641237","Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection","Roberts ES, Huitron-Resendiz S, Taffe MA, Marcondes MC, Flynn CT, Lanigan CM, Hammond JA, Head SR, Henriksen SJ, Fox HS.","J Neurosci. 2006 Apr 26;26(17):4577-85. doi: 10.1523/JNEUROSCI.4504-05.2006.","Roberts ES","J Neurosci","2006","2006/04/28","PMC6674066","","10.1523/JNEUROSCI.4504-05.2006"
"29404757","Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP","Hartmann M, McConnell M, Bekker LG, Celum C, Bennie T, Zuma J, van der Straten A.","AIDS Behav. 2018 Nov;22(11):3468-3479. doi: 10.1007/s10461-018-2044-2.","Hartmann M","AIDS Behav","2018","2018/02/07","PMC6077112","NIHMS940184","10.1007/s10461-018-2044-2"
"15922953","Current status of gene therapy strategies to treat HIV/AIDS","Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ, Rossi JJ, Zaia JA.","Mol Ther. 2005 Jun;11(6):823-42. doi: 10.1016/j.ymthe.2005.01.020.","Strayer DS","Mol Ther","2005","2005/06/01","","","10.1016/j.ymthe.2005.01.020"
"29855550","Epigallocatechin-3-gallate local pre-exposure application prevents SHIV rectal infection of macaques","Liu JB, Li JL, Zhuang K, Liu H, Wang X, Xiao QH, Li XD, Zhou RH, Zhou L, Ma TC, Zhou W, Liu MQ, Ho WZ.","Mucosal Immunol. 2018 Jul;11(4):1230-1238. doi: 10.1038/s41385-018-0025-4. Epub 2018 May 31.","Liu JB","Mucosal Immunol","2018","2018/06/02","PMC6030487","NIHMS955367","10.1038/s41385-018-0025-4"
